Corcept Therapeutics (CORT)
Create an Alert
1.79
-0.04 -2.19%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Corcept Therapeutics Interest Expense:
1.141M for March 31, 2013Corcept Therapeutics Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.141M |
| Dec. 31, 2012 | 1.144M |
| Sept. 30, 2012 | 0.622M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.005M |
| Dec. 31, 2011 | 0.008M |
| Sept. 30, 2011 | 0.001M |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.00 |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| Dec. 31, 2009 | 0.00 |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
CORT Interest Expense Benchmarks
| Companies | |
|---|---|
| Mast Therapeutics | 0.00 |
| Shire | 9.10M |
| Codexis | 0.00 |
CORT Interest Expense Rankings
| Overall |
58th percentile 7008 of 16782 |
| Sector |
43rd percentile 792 of 1410 in Healthcare |
| Industry |
34th percentile 297 of 454 in Biotechnology |
CORT Interest Expense Range, Past 5 Years
| Minimum | 0.000 | Jun 2008 |
| Maximum | 1.144M | Dec 2012 |
| Average | 0.1460M |
